Table 1.
The half-maximal inhibitory concentration (IC50) of FWGE treatment alone or combined with chemotherapeutic drugs. The tumor cell suppression efficiency of FWGE in ES-2 and SKOV-3 cells, as evaluated using IC50s, which was determined by referring to the cell viability data after 48 h of treatment with FWGE alone or combined with chemotherapeutic drugs.
| SKOV-3 | ES-2 | |||
|---|---|---|---|---|
| FWGE (μg/mL) | 643.76 | 246.11 | ||
|
| ||||
| Combination of FWGE (μg/mL) | ||||
| 0 | 200 | 0 | 200 | |
|
| ||||
| Cisplatin (μM) | 7.39 | 1.08 | 1.56 | 0.02 |
| Docetaxel (μM) | 1.49 | 0.05 | 9.53 | 0.91 |